Activation of the protein p7OS6K via ERK phosphorylation by cholinergic muscarinic receptors stimulation in human neuroblastoma cells and in mice brain

Toxicology Letters

Volumn 182, Issue 1-3, 2008, Pages 91-96

  Deguil, Julie ^a   Perault Pochat, Marie Christine ^a,b   Chavant, François ^a,b   Lafay Chebassier, Claire ^a,b   Fauconneau, Bernard ^a,b   Pain, Stéphanie ^a,b  

^a UNIVERSITÉ DE POITIERS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Mice brain; Muscarinic agonist; Neuroblastoma cells; Translational control

Indexed keywords

INITIATION FACTOR 4E; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MUSCARINIC RECEPTOR; OXOTREMORINE; PROTEIN P70;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; HUMAN; HUMAN CELL; MALE; MOUSE; NEUROBLASTOMA CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TRANSLATION REGULATION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CARRIER PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MICE; MICE, INBRED C57BL; MUSCARINIC AGONISTS; NEUROBLASTOMA; OXOTREMORINE; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, MUSCARINIC; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA;

MAMMALIA; MUS;

EID: 54949099935     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.08.012     Document Type: Article

References (38)

1. Asnaghi L., Bruno P., Priulla M., and Nicolin A. mTOR: a protein kinase switching between life and death. Pharmacological Research 50 (2004) 545-549
2. Berkeley J.L., Gomeza J., Wess J., Hamilton S.E., Nathanson N.M., and Levey A.I. M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices. Molecular and Cellular Neuroscience 18 (2001) 512-524
3. Budd D.C., McDonald J., Emsley N., Cain K., and Tobin A.B. The C-terminal tail of the M3-muscarinic receptor possesses anti-apoptotic properties. Journal of Biological Chemistry 278 (2003) 19565-19573
4. Budd D.C., Spragg E.J., Ridd K., and Tobin A.B. Signalling of the M3-muscarinic receptor to the anti-apoptotic pathway. Biochemistry Journal 381 (2004) 43-49
5. Clemens M.J. Translational regulation in cell stress and apoptosis. Role of the eIF4E binding proteins. Journal of Cellular and Molecular Medicine 5 (2001) 221-239
6. De Sarno P., Shestopal S.A., King T.D., Zmijewska A., Song L., and Jope R.S. Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibition. Journal of Biological Chemistry 278 (2003) 11086-11093
7. De Sarno P., Shestopal S.A., Zmijewska A.A., and Jope R.S. Anti-apoptotic effects of muscarinic receptor activation are mediated by Rho kinase. Brain Research 1041 (2005) 112-115
8. Dever T.E. Gene-specific regulation by general translation factors. Cell 108 (2002) 545-556
9. Dorje F., Wess J., Lambrecht G., Tacke R., Mutschler E., and Brann M.R. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. Journal of Pharmacology and Experimental Therapeutics 256 (1991) 727-733
10. Dufner A., and Thomas G. Ribosomal S6 kinase signaling and the control of translation. Experimental Cellular Research 253 (1999) 100-109
11. Duncan R.F., and Hershey J.W. Protein synthesis and protein phosphorylation during heat stress, recovery, and adaptation. Journal of Cellular Biology 109 (1989) 1467-1481
12. Fujino H., Uehara T., Murayama T., Okuma Y., Ariga H., and Nomura Y. Extracellular signal regulated protein kinase and c-jun N-terminal kinase are involved in ml muscarinic receptor-enhanced interleukin-2 production pathway in Jurkat cells. Biological and Pharmacological Bulletin 23 (2000) 1198-1205
13. Fukuda K., Higashida H., Kubo T., Maeda A., Akiba I., Bujo H., Mishina M., and Numa S. Selective coupling with K + currents of muscarinic acetylcholine receptor subtypes in NG108-15 cells. Nature 335 (1988) 355-358
14. Gingras A.C., Raught B., Gygi S.P., Niedzwiecka A., Miron M., Burley S.K., Polakiewicz R.D., Wyslouch-Cieszynska A., Aebersold R., and Sonenberg N. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes and Development 15 (2001) 2852-2864
15. Gingras A.C., Raught B., and Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annual Review of Biochemistry 68 (1999) 913-963
16. Gingras A.C., Raught B., and Sonenberg N. Control of translation by the target of rapamycin proteins. Progress in Molecular and Subcellular Biology 27 (2001) 143-174
17. Jimenez E., and Montiel M. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells. Journal of Cellular Physiology 204 (2005) 678-686
18. Lafay-Chebassier C., Paccalin M., Page G., Barc-Pain S., Perault-Pochat M.C., Gil R., Pradier L., and Hugon J. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. Journal of Neurochemistry 94 (2005) 215-225
19. Lafay-Chebassier C., Pérault-Pochat M.C., Page G., Rioux Bilan A., Damjanac M., Pain S., Houeto J.L., Gil R., and Hugon J. The immunosuppressant rapamycin exacerbates neurotoxicity of Abeta peptide. Journal of Neuroscience Research 84 (2006) 1323-1334
20. Lambert D.G., Ghataorre A.S., and Nahorski S.R. Muscarinic receptor binding characteristics of a human neuroblastoma SK-N-SH and its clones SH-SY5Y and SH-EP1. European Journal of Pharmacology 165 (1989) 71-77
21. Latres E., Amini A.R., Amini A.A., Griffiths J., Martin F.J., Wei Y., Lin H.C., Yancopoulos G.D., and Glass D.J. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. Journal of Biological Chemistry 280 (2005) 2737-2744
22. Leloup C., Michaelson D.M., Fisher A., Hartmann T., Beyreuther K., and Stein R. M1 muscarinic receptors block caspase activation by phosphoinositide 3-kinase- and MAPK/ERK-independent pathways. Cell Death and Differentiation 7 (2000) 825-833
23. Levey A.I., Kitt C.A., Simonds W.F., Price D.L., and Brann M.R. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. Journal of Neuroscience 11 (1991) 3218-3226
24. Lindenboim L., Pinkas-Kramarski R., Sokolovsky M., and Stein R. Activation of muscarinic receptors inhibits apoptosis in PC12M1 cells. Journal of Neurochemistry 64 (1995) 2491-2499
25. Linseman D.A., Heidenreich K.A., and Fisher S.K. Stimulation of M3 muscarinic receptors induces phosphorylation of the Cdc42 effector activated Cdc42Hs-associated kinase-1 via a Fyn tyrosine kinase signaling pathway. Journal of Biological Chemistry 276 (2001) 5622-5628
26. Linseman D.A., Hofmann F., and Fisher S.K. A role for the small molecular weight GTPases, Rho and Cdc42, in muscarinic receptor signaling to focal adhesion kinase. Journal of Neurochemistry 74 (2000) 2010-2020
27. Paccalin M., Pain-Barc S., Pluchon C., Paul C., Bazin H., Gil R., and Hugon J. The relation between p70S6k expression in lymphocytes and the decline of cognitive test scores in patients with Alzheimer disease. Archives of Internal Medicine 165 (2005) 2428-2429
28. Paccalin M., Pain-Barc S., Pluchon C., Paul C., Besson M.N., Carret-Rebillat A.S., Rioux-Bilan A., Gil R., and Hugon J. Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 22 (2006) 320-326
29. Proud C.G. Protein phosphorylation in translational control. Current Topics in Cellular Regulation 32 (1992) 243-369
30. Raught B., Gingras A.C., and Sonenberg N. The target of rapamycin (TOR) proteins. Proceedings of the National Academy of Sciences 98 (2001) 7037-7044
31. Riesterer O., Zingg D., Hummerjohann J., Bodis S., and Pruschy M. Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells. Oncogene 23 (2004) 4624-4635
32. Robinson M.J., and Cobb M.H. Mitogen-activated protein kinase pathways. Current Opinion Cell Biology 9 (1997) 180-186
33. Schmelzle T., and Hall M.N. mTOR, a central controller of cell growth. Cell 103 (2000) 253-262
34. Schmidt M., Lohmann B., Hammer K., Haupenthal S., Nehls M.V., and Jakobs K.H. Gi- and protein kinase C-mediated heterologous potentiation of phospholipase C signaling by G protein-coupled receptors. Molecular Pharmacology 53 (1998) 1139-1148
35. Tang X., Wang L., Proud C.G., and Downes C.P. Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase. Biochemistry Journal 374 (2003) 137-143
36. Waskiewicz A.J., Flynn A., Proud C.G., and Cooper J.A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO Journal 16 (1997) 1909-1920
37. Waskiewicz A.J., Johnson J.C., Penn B., Mahalingam M., Kimball S.R., and Cooper J.A. Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo. Molecular and Cellular Biology 19 (1999) 1871-1880
38. Yan G.M., Lin S.Z., Irwin R.P., and Paul S.M. Activation of muscarinic cholinergic receptors blocks apoptosis of cultured cerebellar granule neurons. Molecular Pharmacology 47 (1995) 248-257